A3 Adenosine Receptor Agonist Reduces Brain Ischemic Injury and Inhibits Inflammatory Cell Migration in Rats
In Young Choi,Jae Chul Lee,Chung Ju,Sunyoung Hwang,G. Cho,Hyuk Woo Lee,Won Jun Choi,Lak Shin Jeong,Won Ki Kim +8 more
Reads0
Chats0
TLDR
The present findings indicate that postischemic activation of A3AR and the resultant reduction of inflammatory response should provide a promising therapeutic strategy for the treatment of ischemic stroke.Abstract:
A3 adenosine receptor (A3AR) is recognized as a novel therapeutic target for ischemic injury; however, the mechanism underlying anti-ischemic protection by the A3AR agonist remains unclear. Here, we report that 2-chloro- N 6 -(3-iodobenzyl)-5′- N -methylcarbamoyl-4′-thioadenosine (LJ529), a selective A3AR agonist, reduces inflammatory responses that may contribute to ischemic cerebral injury. Postischemic treatment with LJ529 markedly reduced cerebral ischemic injury caused by 1.5-hour middle cerebral artery occlusion, followed by 24-hour reperfusion in rats. This effect was abolished by the simultaneous administration of the A3AR antagonist MRS1523, but not the A2AAR antagonist SCH58261. LJ529 prevented the infiltration/migration of microglia and monocytes occurring after middle cerebral artery occlusion and reperfusion, and also after injection of lipopolysaccharides into the corpus callosum. The reduced migration of microglia by LJ529 could be related with direct inhibition of chemotaxis and down-regulation of spatiotemporal expression of Rho GTPases (including Rac, Cdc42, and Rho), rather than by biologically relevant inhibition of inflammatory cytokine/chemokine release (eg, IL-1β, TNF-α, and MCP-1) or by direct inhibition of excitotoxicity/oxidative stress (not affected by LJ529). The present findings indicate that postischemic activation of A3AR and the resultant reduction of inflammatory response should provide a promising therapeutic strategy for the treatment of ischemic stroke.read more
Citations
More filters
Journal ArticleDOI
Pharmacology of Adenosine Receptors: The State of the Art
TL;DR: An overview of current knowledge on adenosine receptors, including their characteristic structural features, molecular interactions and cellular functions, as well as their essential roles in pain, cancer, and neurodegenerative, inflammatory, and autoimmune diseases are offered.
Journal ArticleDOI
How does adenosine control neuronal dysfunction and neurodegeneration
TL;DR: The adenosine modulation system mostly operates through inhibitory A1 (A1R) and facilitatory A2A receptors (A2AR) in the brain, and simultaneously bolstering A1R preconditioning and preventing excessive A2AR function might afford maximal neuroprotection.
Journal ArticleDOI
Purinergic Signaling and Blood Vessels in Health and Disease
Geoffrey Burnstock,Vera Ralevic +1 more
TL;DR: The long-term (trophic) actions of purine and pyrimidine nucleosides and nucleotides in promoting migration and proliferation of both vascular smooth muscle and endothelial cells via P1 and P2Y receptors during angiogenesis and vessel remodeling during restenosis after angioplasty are described.
Journal ArticleDOI
The A3 Adenosine Receptor: History and Perspectives
Pier Andrea Borea,Katia Varani,Fabrizio Vincenzi,Pier Giovanni Baraldi,Mojgan Aghazadeh Tabrizi,Stefania Merighi,Stefania Gessi +6 more
TL;DR: It will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.
Journal ArticleDOI
Neurotransmitter signaling in the pathophysiology of microglia
TL;DR: How altered neurotransmission following acute insults or chronic neurodegenerative conditions modulates microglial functions is still poorly understood.
References
More filters
Journal ArticleDOI
Rho GTPases and the Actin Cytoskeleton
TL;DR: Members of the Rho family of small guanosine triphosphatases have emerged as key regulators of the actin cytoskeleton, and through their interaction with multiple target proteins, they ensure coordinated control of other cellular activities such as gene transcription and adhesion.
Journal ArticleDOI
Pathobiology of ischaemic stroke: an integrated view
TL;DR: This article provides a framework that can be used to generate testable hypotheses and treatment strategies that are linked to the appearance of specific pathophysiological events within the ischaemic brain.
Journal ArticleDOI
A Semiautomated Method for Measuring Brain Infarct Volume
Raymond A. Swanson,Raymond A. Swanson,Matthew T. Morton,George Tsao-Wu,George Tsao-Wu,Robert A. Savalos,Robert A. Savalos,Charisse Davidson,Charisse Davidson,Frank R. Sharp,Frank R. Sharp +10 more
TL;DR: An accurate, reproducible method for determining the infarct volumes of gray matter structures is presented for use with presently available image analysis systems, which minimizes the error that is introduced by edema, which distorts and enlarges theinfarcted tissue and surrounding white matter.
Book ChapterDOI
RHO Gtpases and the Actin Cytoskeleton
Hai Li,Zhenbiao Yang +1 more
TL;DR: Emerging evidence suggests that Rop also regulates actin organization and thus plays a crucial role in the control of cell morphogenesis in plants.
Journal ArticleDOI
Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture Neurological and Pathological Evaluation of an Improved Model
TL;DR: Reversible MCAo in which a poly-L-lysine-coated intraluminal suture was used proved to be a reliable and effective modification of this technique, yielding consistently larger infarcts and greatly reduced interanimal variability.